DOCTORS'
Medical Case Studies
DOCTORS'
Medical Case Studies
Gleevec
Imatinib
Imatinib (originally STI571) is a drug used to treat certain types of cancer. It is currently marketed by Novartis as Gleevec or Glivec as its mesylate salt, imatinib mesilate. It is used in treating chronic myelogenous leukemia (CML), gastrointestinal stromal tumors (GISTs) and some other diseases. By 2011, Gleevec has been FDA approved to treat ten different cancers. In CML, the tyrosine kinase enzyme ABL is stuck in its activated form. It induces the abnormal phenotypes of CML, such as: excessive proliferation and high white blood cell count...
Gleevec - List of case studies
- Drugs
-
Glatiramer Glatirameracetate Gleevac Gleevec Glibenclamide Globulins Glucocorticoids Glucoseamin ...
- Anaplastic Astrocytoma in the left temporal lobe
-
Can also consider Gleevec+ hydrea Desjardins A, Quinn JA, Vredenburgh JJ, ... Tarceva, rapamycin, EGFR inhibitors, mTOR inhibitors, Gleevec, hydrea, imatinib mesylate, hydroxyurea. Treatments ... Tarceva, rapamycin, EGFR inhibitors, mTOR inhibitors, Gleevec, hydrea, imatinib mesylate, hydroxyurea. ...
- Glioblastoma
-
Can also consider Gleevec+ hydrea Desjardins A, Quinn JA, Vredenburgh JJ, ... , EGFR inhibitors , mTOR inhibitors , Gleevec, hydrea , imatinib mesylate , hydroxyurea . ... , EGFR inhibitors , mTOR inhibitors , Gleevec, hydrea , imatinib mesylate , hydroxyurea . ...